📋 Tender Overview
Contract awarded for Centralized framework agreement for 24 months for the supply of medicines xiii/2024 { "detected_language": "romanian", "translated_text": "lot-0004, title: acyclovir type combinations 400 mg ® or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0009, title: alprazolam type combinations 0.5mg, frontin 0.5mg, xanax 0.5mg or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0019, title: captopril type combinations 25 mg ®, captopril lph 25 mg ® or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0020, title: cefaclorum arena type combinations 500 mg, cefaclorul terapia 500 mg ® or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0024, title: dermovate cream type combinations ® or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0031, title: refen retard type combinations 100 mg ® or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0032, title: detralex type combinations 500 mg ® or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0048, title: gabapentin arena type combinations 100 mg, grimodin 100 mg or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0049, title: fluconazole type combinations 100 mg ® or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0051, title: diurex type combinations ®, diurocard ® or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0056, title: indomethacin type combinations 50 mg ® or equivalent, description: the product description, minimum and maximum quantities, both under the framework agreement and under the subsequent contract, as well as the estimated values can be found in the specifications document. according to the specifications document, the minimum and maximum quantities under both the framework agreement and the subsequent contract, as well as the estimated values can be found in the specifications document - chapter 9. lot-0060, title: kanamycin sulfate h type combinations ® or equi estimated value excluding vat: 7150.00 ron.Centralized framework agreement for 24 months for the supply of medicines xiii/2024
